www.fdanews.com/articles/198100-profound-ai-breast-cancer-solution-gets-ce-mark
ProFound AI Breast Cancer Solution Gets CE Mark
July 17, 2020
ProFound AI has received CE Mark certification for Risk, a tool used to assess breast cancer risk in women.
The supportive solution provides a two-year risk assessment of a patient’s breast cancer based on a screening mammogram that is personalized to the patient.
The tool weighs a number of risk factors, including age, breast density and mammographic features, to help improve breast screening regimens and potentially spot cancers earlier.